Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 131 entries
View as:

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01146938 Org: User:
Start: 05/31/10 End: 02/28/11 Due: 02/28/12

A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00938197 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00386529 Org: User:
Start: 09/30/06 End: 08/31/08 Due: 08/31/09

BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)

Phase: N/A Priority: Normal
NCT ID: NCT04018248 Org: User:
Start: 04/21/20 End: 03/31/24 Due: 03/31/25

An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria

Phase: N/A Priority: Normal
NCT ID: NCT05086549 Org: User:
Start: 09/29/21 End: 06/05/23 Due: 06/05/24

VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04151615 Org: User:
Start: 11/15/18 End: 01/11/23 Due: 01/11/24

Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01150942 Org: User:
Start: 08/31/10 End: 02/28/13 Due: 02/28/14

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05959499 Org: User:
Start: 07/13/23 End: 09/12/23 Due: 09/12/24

A Phase IV Clinical Study to Compared the Efficacy and Safety of Switching Metformin+SGLT2-i+DPP4-i to Metformin+SGLT2-i+TZD in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06972732 Org: User:
Start: 05/30/25 End: 10/01/26 Due: 10/01/27

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03250052 Org: User:
Start: 08/14/17 End: 11/21/17 Due: 11/21/18

A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

Phase: N/A Priority: Normal
NCT ID: NCT06165237 Org: User:
Start: 03/30/23 End: 05/09/23 Due: 05/09/24

A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01007409 Org: User:
Start: 10/31/09 End: - Due: -

Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)

Phase: N/A Priority: Normal
NCT ID: NCT02394392 Org: User:
Start: 07/31/14 End: 10/31/15 Due: 10/31/16

BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination

Phase: N/A Priority: Normal
NCT ID: NCT03991442 Org: User:
Start: 06/17/19 End: 03/02/21 Due: 03/02/22

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01289886 Org: User:
Start: 09/30/03 End: 12/31/03 Due: 12/31/04

A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02920931 Org: User:
Start: 02/29/16 End: 04/30/16 Due: 04/30/17

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Phase: N/A Priority: Normal
NCT ID: NCT05413057 Org: User:
Start: 06/23/22 End: 06/30/26 Due: 06/30/27

A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05097794 Org: User:
Start: 08/16/21 End: 10/22/21 Due: 10/22/22

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06008015 Org: User:
Start: 09/04/23 End: 10/03/23 Due: 10/03/24

The Effects of Cilnidipine on Metabolic Syndrome Improvement

Phase: N/A Priority: Normal
NCT ID: NCT00325936 Org: User:
Start: 07/31/05 End: 06/30/07 Due: 06/30/08

A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.

Phase: N/A Priority: Normal
NCT ID: NCT06126016 Org: User:
Start: 10/19/23 End: 04/30/26 Due: 04/30/27

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01148368 Org: User:
Start: 06/30/10 End: 07/31/11 Due: 07/31/12

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06744062 Org: User:
Start: 01/05/25 End: 03/19/25 Due: 03/19/26

FimasaRtan-basEd BP Targets After Drug SwitcHing

Phase: N/A Priority: Normal
NCT ID: NCT03649646 Org: User:
Start: 07/03/18 End: 10/29/20 Due: 10/29/21

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06744127 Org: User:
Start: 01/03/25 End: 03/14/25 Due: 03/14/26